Globus Medical Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Globus Medical (GMED) PT Raised to $78 at RBC Capital
August 7, 2024 7:00 AM EDTRBC Capital analyst Shagun Singh raised the price target on Globus Medical (NYSE: GMED) to $78.00 (from $76.00) while maintaining a Outperform rating.
The analyst comments "GMED issued Q2 results, delivering an upside surprise of 2% and 11% in sales and EPS, respectively. This was the third consolidated... More
Globus Medical (GMED) PT Raised to $79 at Truist Securities
August 7, 2024 6:08 AM EDTTruist Securities analyst Richard Newitter raised the price target on Globus Medical (NYSE: GMED) to $79.00 (from $78.00) while maintaining a Hold rating.
The analyst comments "GMED delivered a good qtr, post-deal integration with dissynergies no worse than feared, and mgmt appears on... More
Globus Medical (GMED) PT Raised to $100 at Roth/MKM
August 7, 2024 5:17 AM EDTRoth/MKM analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 (from $75.00) while maintaining a Buy rating.
The analyst comments "GMED reported 2Q24 revenues of $629.7 million compared to consensus of $615.3 million, and adjusted EPS of $0.75 compared to consensus of $0.68. Adjusted... More
